Choosing a model line for what the experiment has to conclude: why an mc38 cell line and other syngeneic mouse lines exist so that a tumour can grow in an animal with an intact immune system and what that constrains about strain background, where a human line answers a target question the mouse line cannot, what a gaussia luciferase reporter and other secreted reporters add in longitudinal readout, how a tsg101 exosome marker and similar reagents are used to characterise what the line releases, why an antibody arrays panel is a screen rather than a measurement, and what has to be documented about any model line before results from it transfer

A model line is chosen for the question it makes answerable, not for how well it represents a tumour. Syngeneic lines exist so that immunology can be studied in an animal with a working immune system, and they are mouse biology; human lines answer human target questions and need an immunodeficient host.

the ICH guideline on characterisation of cell substrates
Q5D
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the biosafety manual that decides handling for cultured lines
BMBL

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.

Choosing and documenting a model

  1. Match the line to the host strain. A syngeneic line only grows without rejection in the strain it came from. Using it in another background produces a rejection experiment, which is occasionally the point and usually not.
  2. Decide whether the question is target or immune. Human target pharmacology usually needs a human line and an immunodeficient host, which removes the immune system from the model. Immune questions need a competent host and therefore mouse biology. Very few models give both.
  3. Use a secreted reporter for longitudinal work. A reporter released into blood or medium allows repeated measurement without sacrificing the animal or the culture, which reduces numbers and increases statistical power.
  4. Characterise what the line releases if that is the subject. Vesicles, cytokines and metabolites released by a line are part of its phenotype and vary with confluence and medium. Characterise them under the conditions of the experiment rather than from the literature.
  5. Treat array screens as hypothesis generators. A multiplex array indicates which analytes changed and at what approximate magnitude. Confirming with a quantitative assay for the ones that matter is what turns a screen into a result.
  6. Document the line as you would a reagent. Source, passage, authentication, screening and the exact growth conditions. Model results that cannot be reproduced usually differ in one of those five.

Every model excludes something

A model is chosen by what it lets you observe, and every choice removes something else. Naming what the model excludes, in the write up, is what keeps the conclusion proportionate.

Where the excluded element is central to the claim, a second model with the opposite trade is the standard answer.

Culture conditions travel with the result

Confluence, medium, serum lot and passage change growth rate, immunogenicity and what a line secretes. Two laboratories using the same line under different conditions are running different experiments.

Record those four alongside the line name. It is the difference between a reproducible model and a familiar one.

Common questions

Why use a syngeneic line?
Because it grows in an immunocompetent animal of the matching strain, which is the only way to study an immune response to a tumour in vivo. The cost is that the biology is mouse rather than human.
Can a human line be used in an immunocompetent host?
No, it is rejected. Human lines require an immunodeficient or humanised host, and that choice removes or reshapes exactly the immune biology a syngeneic model preserves.
Are array screens quantitative?
Semi quantitative at best. They rank and indicate magnitude across many analytes, and anything a conclusion depends on should be confirmed with a validated single analyte assay.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/mc38-cell-line/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices